Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 13/20 | 0.41 |
| ▸ | TERT | O14746 | 1/20 | 0.37 |
| ▸ | GPR3 | P46089 | 2/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL29657137 | 1.00 | PTPN1 (0.43) | PTPN1KCNH2TERTGPR3ACHE | |
| Trifluoromethanesulfonic Acid SCHEMBL23356582 | 0.82 | MEN1 (0.38) | KCNH2TERTGPR3ACHE | |
| Trifluoromethanesulfonic Acid SCHEMBL23356585 | 0.80 | NSD2 (0.43) | KCNH2TERTGPR3ACHE | |
| Trifluoromethanesulfonic Acid SCHEMBL3855070 | 0.80 | KCNH2 (0.43) | KCNH2GPR3ACHE | |
| Trifluoromethanesulfonic Acid SCHEMBL11070907 | 0.79 | KCNH2 (0.36) | KCNH2TERTGPR3ACHE | |
| Trifluoromethanesulfonic Acid SCHEMBL7077338 | 0.78 | GPR3 (0.41) | KCNH2GPR3ACHE | |
| Trifluoromethanesulfonic Acid SCHEMBL31683143 | 0.78 | GPR3 (0.41) | KCNH2GPR3ACHE | |
| Trifluoromethanesulfonic Acid SCHEMBL20495457 | 0.76 | GPR3 (0.39) | KCNH2GPR3ACHE | |
| Trifluoromethanesulfonic Acid SCHEMBL11070399 | 0.75 | KCNH2 (0.38) | PTPN1KCNH2GPR3ACHE | |
| Biphenyl SCHEMBL31361248 | 0.75 | PTPN1 (0.56) | PTPN1KCNH2GPR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11286240-B2 | Catalyst bound alpha radical and synthesis of OXO compounds using the same | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2022-03-29 | — | — | US | claimed |
| US-20210147364-A1 | A CATALYST BOUND ALPHA RADICAL AND SYNTHESIS OF OXO COMPOUNDS USING THE SAME | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2021-05-20 | — | — | US | claimed |
| US-11286240-B2 | Catalyst bound alpha radical and synthesis of OXO compounds using the same | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2022-03-29 | — | — | US | disclosed |
| US-20210147364-A1 | A CATALYST BOUND ALPHA RADICAL AND SYNTHESIS OF OXO COMPOUNDS USING THE SAME | COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) | 2021-05-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11286240-B2 | Catalyst bound alpha radical and synthesis of OXO compounds using the same | CBR1, POR, CAT | PTPN1 4674/4885KCNH2 1920/4885TERT 358/4885 |
| US-20210147364-A1 | A CATALYST BOUND ALPHA RADICAL AND SYNTHESIS OF OXO COMPOUNDS USING THE SAME | CBR1, POR, CAT | PTPN1 4720/4885KCNH2 1380/4885TERT 289/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.